What dose of 20% intralipid (lipid emulsion) in milliliters should be given as an intravenous bolus for a 70‑kg patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lipid Emulsion Dosing for Local Anesthetic Systemic Toxicity in a 70kg Patient

For a 70kg patient with suspected local anesthetic systemic toxicity, administer an initial bolus of 105 mL of 20% Intralipid (1.5 mL/kg) over 1 minute, followed by a continuous infusion of 1050 mL/hour (0.25 mL/kg/min or 15 mL/kg/hr).

Initial Bolus Dosing

The standardized protocol across multiple guidelines is remarkably consistent 1, 2, 1, 2:

  • Initial bolus: 1.5 mL/kg of 20% lipid emulsion over approximately 1 minute
  • For 70kg patient: 105 mL over 1 minute

This bolus can be repeated up to two additional times (for a total of three boluses) at 5-minute intervals if cardiovascular collapse persists 2. Each repeat bolus would be another 100-105 mL for a 70kg patient.

Continuous Infusion

Following the initial bolus, immediately start a continuous infusion 1, 2, 1:

  • Infusion rate: 0.25 mL/kg/min (equivalent to 15 mL/kg/hr)
  • For 70kg patient: 17.5 mL/min or 1050 mL/hour

Dose Escalation Protocol

If adequate circulation is not restored after 5 minutes of infusion at the standard rate 2:

  • Double the infusion rate to 0.5 mL/kg/min (30 mL/kg/hr)
  • For 70kg patient: 2100 mL/hour

Continue the infusion for at least 10 minutes after achieving circulatory stability 1.

Maximum Cumulative Dose

Do not exceed 12 mL/kg total cumulative dose 2:

  • For 70kg patient: Maximum 840 mL total

This FDA-established maximum is critical to avoid complications including severe hypertriglyceridemia, metabolic acidosis, and lipid overload syndrome 3, 4.

Clinical Context and Mechanism

The lipid emulsion works through the "lipid sink" mechanism, extracting lipophilic local anesthetics from cardiac tissue and brain into the lipid phase, while also providing direct cardioprotective effects through fatty acid supply and mitochondrial support 2, 5.

Important Caveats

  • Prolonged resuscitation may be necessary - CPR should continue throughout lipid administration, potentially exceeding 1 hour 2
  • Avoid propofol if cardiovascular instability exists during seizure management, as it adds additional lipid load 1
  • Reduce epinephrine doses during resuscitation - standard ACLS epinephrine dosing may be excessive in the presence of lipid emulsion 1
  • Monitor for complications: The infusion can cause pulmonary hypertension, increased vascular resistance, and interference with laboratory measurements 6, 3

Mandatory Reporting

All cases of lipid rescue therapy must be reported to the national adverse event reporting system and the Lipid Rescue registry (www.lipidrescue.org) 2.

Practical Administration

  • Use 20% lipid emulsion (Intralipid is the most studied formulation) 2, 7
  • Can be administered via peripheral or central venous access 8
  • Use a 1.2-micron filter - smaller filters will occlude 8
  • Have cardiopulmonary bypass capability alerted if available, as this may be needed for refractory cases 1, 2

The dosing is weight-based and straightforward: 1.5 mL/kg bolus, then 0.25 mL/kg/min infusion, with potential doubling of infusion rate and repeat boluses as needed, not exceeding 12 mL/kg total.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.